DEA’s Cannabis Incompetence on Full Display: A Parade of Cluelessness and Corruption: TERRY COLE FIX IT!
MMJ is Developing FDA approved cannabis medicines that best serve patients with unmet medical needs.
Terrance Cole’s Choice: Reformer or Cover-Up Artist? New DEA Administrator Terrance Cole stands at a crossroads:
- Break rank, clean house, and restore the DEA’s credibility by approving MMJ BioPharma’s application.
- Or protect the old guard’s corruption and go down as the next puppet in a failed prohibitionist machine.
America doesn’t need more prohibition era crooners in suits. It needs a leader who prioritizes patients over politics, science over bureaucracy, and integrity over careerism.
The DEA’s war on cannabis research is not just a failure of policy-it’s a failure of morality.
WASHINGTON, D.C. – August 5, 2025
While patients suffering from Huntington’s disease, Multiple Sclerosis, and other debilitating conditions await life saving cannabis based treatments, the U.S. Drug Enforcement Administration (DEA) continues to flaunt its profound ignorance, regulatory negligence, and outright corruption. The agency’s mission claims to “ensure an adequate and uninterrupted supply of controlled substances for medical and scientific needs,” but internal statements and actions reveal a shocking pattern of incompetence, deceit, and deliberate obstruction.
From field agents to senior leadership, the DEA’s handling of cannabis research applications has devolved into a circus of bureaucratic malpractice-one that prioritizes power over patients, red tape over science, and self-preservation over public health.
The DEA’s Greatest Hits: A Compilation of Cluelessness and Corruption
Here are actual quotes from DEA officials tasked with overseeing cannabis research-exposing an agency that is either catastrophically inept or intentionally sabotaging medical progress:
- Thomas Cooke, Diversion Investigator, Rhode Island: (2021) “I know nothing about marijuana. Are you growing it in the 10 by 20 vault?”
- Mark Rubins, New England Diversion Supervisor: (2022) “If your doctor doing the clinical trial had a Schedule I Researcher’s Registration previously that expired, just tell him to reapply and DEA Headquarters will approve him.”
- Matthew Strait, DEA Deputy Policy Administrator: (2023) “The other applicants that got approved just did the Bona Fide Supply Agreement with the DEA purchasing the marijuana from the growers-that will be OK.”
- Ricardo Quintero, DEA Section Chief: (2023) “Oh, you are calling about your MMJ bulk manufacturing application? And why do you want to know?”
- Aarathi Haig, DEA Chief Counsel (to MMJ’s attorney Megan Sheehan): (2024) “Oh, the DEA will settle your litigation-just have your client withdraw their application, and we will expedite their new one.”
- Thomas Prevoznik, DEA Deputy Administrator (in a formal letter to MMJ): (2024) “After a careful review of your application and consistent with my obligation to ensure public safety under the Controlled Substances Act (21 U.S.C. 801, et. seq.), I deny the request to discontinue or defer administrative proceedings. Furthermore, I have determined there is no potential modification of your application that could or would alter my decision in this regard.”
The Bigger Scandal: A Culture of Corruption
These quotes are not isolated incidents-they reflect a systemic rot within the DEA’s Diversion Control Division:
- Fraudulent Licensing: The DEA rubber-stamped eight cannabis research licenses between 2021-2022, but seven are inactive, bankrupt, or non-compliant. One was even set up in a garage.
- Unconstitutional Tactics: The DEA dragged MMJ into an administrative law tribunal that the Supreme Court has since ruled unconstitutional (Axon v. FTC, Jarkesy v. SEC).
- Ethical Violations: DEA attorney Aarathi Haig remains on the case despite her lapsed bar standing, violating 28 U.S.C. § 530B (requiring federal attorneys to comply with state ethics rules).
The Human Cost: Patients Left to Suffer
While the DEA plays bureaucratic games:
- Huntington’s Disease patients face a 10-20 year death sentence with no effective treatments.
- Multiple Sclerosis patients endure irreversible nerve damage while the DEA blocks potential therapies.
- Children with epilepsy are denied FDA-approved cannabis medicines, while contaminated street products flood the market unchecked.
The Solution: Dismantle the DEA’s Obstruction Machine
Congress, the courts, and the White House must act now:
- Fire the Culprits: Prevoznik, Strait, Haig, Quintero, Cooke, and Rubins must be removed and investigated.
- Transfer Oversight: Cannabis research should be moved to the FDA or NIH, where science-not stigma-guides policy.
- End Unconstitutional Tribunals: The DEA’s rigged Administrative Law Judge system must be dismantled per Supreme Court rulings .
Terrance Cole’s Moment of Truth (2025)
New DEA Administrator Terrance Cole faces a choice:
- Continue the cover-up, protecting the corrupt officials who sabotaged medical research.
- Or clean house, approve MMJ’s application, and end this national disgrace.
America doesn’t need more anti-science bureaucrats-it needs leaders who put patients over politics.
The DEA’s cannabis obstruction isn’t just incompetence-it’s institutional malpractice.
MMJ is represented by attorney Megan Sheehan.
Filed under: General Problems
So why aren’t you supporting getting the CSA repealed?
@PharmacistSteve I Thoroughly enjoy reading every article you print about the Medical System, Medicine, Insurance, and All Things Medical. You always share the most recent and important information and I can relate to all of it! Thank You!
thanks… I try to share, educate, motivate pts to advocate for themselves. Unfortunately, everyone is on their own!